Blue Jet Healthcare Limited (BLUEJET.NS)
- Previous Close
723.30 - Open
707.00 - Bid --
- Ask --
- Day's Range
702.10 - 729.40 - 52 Week Range
347.60 - 968.30 - Volume
120,036 - Avg. Volume
479,477 - Market Cap (intraday)
125.892B - Beta (5Y Monthly) --
- PE Ratio (TTM)
53.63 - EPS (TTM)
13.53 - Earnings Date May 14, 2025
- Forward Dividend & Yield 1.00 (0.14%)
- Ex-Dividend Date Sep 18, 2024
- 1y Target Est
855.83
Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norway, France, the United States, Italy, Sweden, Spain, and internationally. Blue Jet Healthcare Limited was incorporated in 1968 and is headquartered in Thane, India.
www.bluejethealthcare.comRecent News: BLUEJET.NS
View MorePerformance Overview: BLUEJET.NS
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BLUEJET.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BLUEJET.NS
View MoreValuation Measures
Market Cap
125.58B
Enterprise Value
121.85B
Trailing P/E
53.42
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
14.38
Price/Book (mrq)
13.58
Enterprise Value/Revenue
13.97
Enterprise Value/EBITDA
36.52
Financial Highlights
Profitability and Income Statement
Profit Margin
26.88%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
8.73B
Net Income Avi to Common (ttm)
2.35B
Diluted EPS (ttm)
13.53
Balance Sheet and Cash Flow
Total Cash (mrq)
3.64B
Total Debt/Equity (mrq)
0.12%
Levered Free Cash Flow (ttm)
--